ArticleBMC infectious diseases2016

Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis.

Nadia Valin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.